Women at higher risk of miscarriage to be offered hormone drug by NHS

Charities say Nice’s decision to endorse progesterone for some cases in England will help save babies’ lives

Women at a higher risk of miscarriage in England are to be offered a hormone drug under new NHS guidelines.

The National Institute for Health and Care Excellence (Nice) has published updated guidance on miscarriage that says certain women can be offered progesterone to help prevent pregnancy loss.

Pregnancy and baby loss charities welcomed the move, which they said would help save babies’ lives and spare parents heartache. However, Nice cautioned the drug would not be able to prevent every miscarriage and would only be appropriate for use by some women.

Prof Gillian Leng, Nice’s chief executive, said: “It is devastating for a woman to experience a miscarriage, so we are pleased to recommend progesterone for those women who experience bleeding in early pregnancy and who have had at least one miscarriage as a new treatment option.

“The research evidence is clear that progesterone will not be able to prevent every miscarriage, and therefore our committee has called for more research to be carried out in this area. However, it will be of benefit to some women and as an inexpensive treatment option can be made available to women on the NHS from today.”

Nice said women who have previously had a miscarriage and have a pregnancy confirmed by scan who are bleeding can be offered 400mg of micronised progesterone twice daily. If a foetal heartbeat is confirmed, it is recommended treatment with progesterone should continue until 16 weeks of pregnancy have been completed.

Nice estimates about 7,200 women with prior miscarriage and bleeding in early pregnancy could be eligible for treatment with progesterone each year.

Its independent guidelines committee said the hormone should not be offered to women with early pregnancy bleeding but no previous miscarriage, nor in women with previous miscarriage but no early pregnancy bleeding in the current pregnancy. It called for more research in these two areas.

Nice added: “There was no evidence of harm to the mother or baby from the use of progesterone, although the evidence is insufficient to rule out the possibility of rare events.”

Welcoming the update, Jane Brewin, the chief executive of pregnancy and baby loss charity Tommy’s, said: “It’s great to see Nice taking our progesterone research onboard in their new miscarriage care guidelines, which will help save babies’ lives and spare parents heartache. Miscarriage is often dismissed as ‘one of those things’ we can’t do anything about – even by some healthcare professionals, who may not specialise in this area to know the latest evidence.

“We hear from women who were denied progesterone treatment when they should have been eligible, simply because their doctor wasn’t familiar with it, so we hope Nice’s recommendation will help end some of these inequalities in miscarriage care that add more pain to an already unbearable experience.”

Prof Arri Coomarasamy, the director of Tommy’s National Centre for Miscarriage Research at the University of Birmingham, said: “The miscarriage care guidelines from Nice include a very welcome change, after many years researching the use of progesterone and working to make treatment more accessible.

“Our research has shown that progesterone is a robust and effective treatment option but we know it’s not yet reaching everyone who might benefit. This new recommendation from Nice is an important step in tackling the current variation in miscarriage services across the country and preventing these losses wherever possible.”

Dr Edward Morris, the president of the Royal College of Obstetricians and Gynaecologists, said: “The advice in the new Nice guideline on ectopic pregnancy and miscarriage reflects what we are proposing in our draft green-top guideline on recurrent miscarriage, which is that women who experience early pregnancy bleeding and who have a history of one or more previous miscarriages be given progesterone for up to 16 weeks.

“It is positive that Nice has acknowledged the latest evidence available from the Prism trial and how these findings can translate into tangible action for women experiencing recurrent miscarriage. We do, however, still have a way to go before understanding the best treatments for women experiencing unexplained pregnancy loss, and would welcome further research in this area.”


Andrew Gregory Health editor

The GuardianTramp

Related Content

Article image
Doctors call on NHS to offer women more help after first miscarriage
Current rules state support only has to be provided to those who have had three unsuccessful pregnancies

Denis Campbell Health policy editor

19, Oct, 2021 @1:07 PM

Article image
Women in UK ‘seldom’ told drug used in surgery can impede contraception
Study at NHS trust finds no patients were informed of risk of unplanned pregnancy from sugammadex

Andrew Gregory Health editor

02, Jun, 2022 @10:01 PM

Article image
No need for six-month wait to try for baby after pregnancy loss, study finds
Analysis challenges WHO health guidance on amount of time women should delay after miscarriage or abortion

Linda Geddes Science correspondent

22, Nov, 2022 @7:00 PM

Article image
A strategy for women’s health in England: six areas of focus
From gynaecological conditions to healthy ageing, these are expected to be the priorities of the final plan

Andrew Gregory Health editor

23, Dec, 2021 @12:01 AM

Article image
Thousands of women to be offered new tablet for fibroids on NHS
Nice recommends alternative to injections or surgery for treating non-cancerous growths in womb

Andrew Gregory Health editor

13, May, 2022 @10:41 AM

Article image
Women not receiving NHS support after miscarriage, say campaigners
Pregnancy and baby loss charity Tommy’s says 20% of women experience PTSD after miscarriage

Rachel Hall

02, Aug, 2021 @4:28 PM

Article image
Low-risk pregnant women urged to avoid hospital births
NHS guidance from National Institute for Health and Care Excellence suggests 45% of births ‘unsuitable’ for labour wards

Haroon Siddique

03, Dec, 2014 @12:02 AM

Article image
NHS told to improve care of pregnant women carrying twins or triplets

Nice has issued guidance on how health professionals should manage multiple births after discovering wide variations

Denis Campbell, health correspondent

27, Sep, 2011 @11:05 PM

Article image
Caroline Criado Perez demands end of NHS Covid partner ban after having miscarriage alone
Feminist campaigner says practice is ‘traumatising’ and ‘inhumane’

Alexandra Topping

09, Dec, 2020 @5:24 PM

Article image
Woman stored baby’s remains in fridge after London hospital refused them
Laura Brody had to deliver son at home after miscarriage and was then told Lewisham A&E could not take remains

Caroline Davies

30, May, 2022 @10:29 AM